Cargando…
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677717/ https://www.ncbi.nlm.nih.gov/pubmed/34916493 http://dx.doi.org/10.1038/s41467-021-27447-6 |
| _version_ | 1784616198830292992 |
|---|---|
| author | Andres-Ejarque, Rosa Ale, Hira Bahadur Grys, Katarzyna Tosi, Isabella Solanky, Shane Ainali, Chrysanthi Catak, Zeynep Sreeneebus, Hemawtee Saklatvala, Jake Dand, Nick de Rinaldis, Emanuele Chapman, Anna Nestle, Frank O. Barnes, Michael R. Warren, Richard B. Reynolds, Nick J. Griffiths, Christopher E. M. Barker, Jonathan N. Smith, Catherine H. Di Meglio, Paola |
| author_facet | Andres-Ejarque, Rosa Ale, Hira Bahadur Grys, Katarzyna Tosi, Isabella Solanky, Shane Ainali, Chrysanthi Catak, Zeynep Sreeneebus, Hemawtee Saklatvala, Jake Dand, Nick de Rinaldis, Emanuele Chapman, Anna Nestle, Frank O. Barnes, Michael R. Warren, Richard B. Reynolds, Nick J. Griffiths, Christopher E. M. Barker, Jonathan N. Smith, Catherine H. Di Meglio, Paola |
| author_sort | Andres-Ejarque, Rosa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8677717 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86777172022-01-04 Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis Andres-Ejarque, Rosa Ale, Hira Bahadur Grys, Katarzyna Tosi, Isabella Solanky, Shane Ainali, Chrysanthi Catak, Zeynep Sreeneebus, Hemawtee Saklatvala, Jake Dand, Nick de Rinaldis, Emanuele Chapman, Anna Nestle, Frank O. Barnes, Michael R. Warren, Richard B. Reynolds, Nick J. Griffiths, Christopher E. M. Barker, Jonathan N. Smith, Catherine H. Di Meglio, Paola Nat Commun Author Correction Nature Publishing Group UK 2021-12-16 /pmc/articles/PMC8677717/ /pubmed/34916493 http://dx.doi.org/10.1038/s41467-021-27447-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Andres-Ejarque, Rosa Ale, Hira Bahadur Grys, Katarzyna Tosi, Isabella Solanky, Shane Ainali, Chrysanthi Catak, Zeynep Sreeneebus, Hemawtee Saklatvala, Jake Dand, Nick de Rinaldis, Emanuele Chapman, Anna Nestle, Frank O. Barnes, Michael R. Warren, Richard B. Reynolds, Nick J. Griffiths, Christopher E. M. Barker, Jonathan N. Smith, Catherine H. Di Meglio, Paola Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis |
| title | Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis |
| title_full | Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis |
| title_fullStr | Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis |
| title_full_unstemmed | Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis |
| title_short | Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis |
| title_sort | author correction: enhanced nf-κb signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677717/ https://www.ncbi.nlm.nih.gov/pubmed/34916493 http://dx.doi.org/10.1038/s41467-021-27447-6 |
| work_keys_str_mv | AT andresejarquerosa authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT alehirabahadur authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT gryskatarzyna authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT tosiisabella authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT solankyshane authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT ainalichrysanthi authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT catakzeynep authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT sreeneebushemawtee authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT saklatvalajake authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT dandnick authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT derinaldisemanuele authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT chapmananna authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT nestlefranko authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT barnesmichaelr authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT warrenrichardb authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT reynoldsnickj authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT griffithschristopherem authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT barkerjonathann authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT smithcatherineh authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT dimegliopaola authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis AT authorcorrectionenhancednfkbsignalingintype2dendriticcellsatbaselinepredictsnonresponsetoadalimumabinpsoriasis |